Twist Bioscience Corp Stock Investor Sentiment
TWST Stock | USD 42.05 0.00 0.00% |
Slightly above 56% of Twist Bioscience's investor base is looking to short. The analysis of the overall investor sentiment regarding Twist Bioscience Corp suggests that many traders are alarmed. Twist Bioscience's investing sentiment can be driven by a variety of factors including economic data, Twist Bioscience's earnings reports, geopolitical events, and overall market trends.
Comfort Level 44
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Twist Bioscience's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Twist Bioscience Corp.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Twist Historical Sentiment
Although Twist Bioscience's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Twist, such as negative comments on social media and news outlets, may cause fear in the market and push Twist Bioscience's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Twist.
Twist |
Twist Bioscience Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Twist Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Twist Bioscience Corp Historical Investor Sentiment
Investor biases related to Twist Bioscience's public news can be used to forecast risks associated with an investment in Twist. The trend in average sentiment can be used to explain how an investor holding Twist can time the market purely based on public headlines and social activities around Twist Bioscience Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Twist Bioscience's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Twist Bioscience and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Twist Bioscience news discussions. The higher the estimate score, the more favorable the investor's outlook on Twist Bioscience.
Twist Bioscience Maximum Pain Price Across April 17th 2025 Option Contracts
Twist Bioscience's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Twist Bioscience close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Twist Bioscience's options.
Far too much social signal, news, headlines, and media speculation about Twist Bioscience that are available to investors today. That information is available publicly through Twist media outlets and privately through word of mouth or via Twist internal channels. However, regardless of the origin, that massive amount of Twist data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Twist Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Twist Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Twist Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Twist Bioscience alpha.
Twist Bioscience Performance against Dow Jones
Price Growth (%) |
Timeline |
1 | Disposition of 1654 shares by Emily Leproust of Twist Bioscience at 44.903 subject to Rule 16b-3 | 12/20/2024 |
2 | Twist Bioscience Is In A Strong Position To Grow Its Business | 12/26/2024 |
3 | Disposition of 546 shares by Emily Leproust of Twist Bioscience at 45.5911 subject to Rule 16b-3 | 01/03/2025 |
4 | Disposition of 5886 shares by Adam Laponis of Twist Bioscience at 43.263 subject to Rule 16b-3 | 01/10/2025 |
5 | Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025 | 01/22/2025 |
6 | Disposition of 2422 shares by Patrick Finn of Twist Bioscience at 50.1654 subject to Rule 16b-3 | 01/23/2025 |
7 | Acquisition by Paula Green of 20428 shares of Twist Bioscience subject to Rule 16b-3 | 01/24/2025 |
8 | Disposition of 1507 shares by Dennis Cho of Twist Bioscience at 47.998 subject to Rule 16b-3 | 01/28/2025 |
9 | Twist Bioscience First Quarter 2025 Earnings Beats Expectations | 02/04/2025 |
10 | Earnings Update Twist Bioscience Corporation Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts | 02/07/2025 |
11 | Twist Bioscience Corp Shares Down 5.37 percent on Feb 10 | 02/10/2025 |
12 | Baillie Gifford Co. Sells 56,802 Shares of Twist Bioscience Co. | 02/18/2025 |
13 | Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635 | 02/19/2025 |
14 | Disposition of 2790 shares by Emily Leproust of Twist Bioscience at 44.177 subject to Rule 16b-3 | 02/21/2025 |
15 | Disposition of 916 shares by Robert Werner of Twist Bioscience at 41.713 subject to Rule 16b-3 | 02/24/2025 |
16 | Twist Bioscience Corp Announces Participation in Upcoming Investor Conferences | 02/25/2025 |
17 | Twist Bioscience Corp Shares Down 4.35 percent on Mar 3 | 03/03/2025 |
18 | Disposition of 241 shares by Robert Werner of Twist Bioscience at 40.913 subject to Rule 16b-3 | 03/06/2025 |
19 | Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost | 03/11/2025 |
20 | Disposition of tradable shares by Dennis Cho of Twist Bioscience at 40.048 subject to Rule 16b-3 | 03/14/2025 |
21 | Farther Finance Advisors LLC Buys 2,028 Shares of Twist Bioscience Co. | 03/19/2025 |
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.